Biosimilars are considered as safe and effective as their parent drugs, and they are often less expensive. So rather than generic forms, biologics are sometimes available as biosimilars. Toujeo is not currently available in biosimilar form.īiologic drugs, such as Toujeo, are made from living cells. It contains a long-acting form of insulin called insulin glargine. The ADA recommends an A1C goal of less than 7.0% for most adults. † A1C is a measurement that shows your average blood sugar levels over the past 2 to 3 months. The American Diabetes Association (ADA) recommends a fasting blood sugar level of 80 mg/dL to 130 mg/dL for most adults. * Fasting blood sugar is measured after you’ve fasted for a certain time. For more information on Toujeo’s effectiveness and how it’s used, see the section below called “ Toujeo uses.” Toujeo is not used to treat diabetic ketoacidosis. fasting blood sugar levels by about 10 mg/dL.The study found that after 26 weeks of treatment, Toujeo lowered their: hemoglobin A1c (A1C) levels† by 0.4% to 1.42%Ī clinical study also tested Toujeo in children ages 6 years or older with type 1 diabetes.fasting blood sugar levels* by 17 to 61 mg/dL.The studies showed that after 26 weeks of treatment, Toujeo lowered their: It can give up to 160 units of insulin glargine in a single injection.Ĭlinical studies tested Toujeo in adults with type 1 or type 2 diabetes. This pen contains 900 units of insulin glargine in 3 mL of solution. It can give up to 80 units of insulin glargine in a single injection. This pen contains 450 units of insulin glargine in 1.5 mL of solution. It’s available in the following two prefilled pens: This drug is given as a subcutaneous injection (an injection under your skin). Toujeo contains insulin glargine, which is a long-acting insulin. It’s FDA-approved to treat type 1 or type 2 diabetes in adults and children ages 6 years and older. We will do our best to find the appropriate resource to help.Toujeo is a brand-name prescription medication. Please feel free to reach out should you have questions. We hope you find this information helpful. Here are the links for those resources.Ĭlick on “get help with costs”, there you can access the My$99 program, savings cards, and patient assistance. Novo Nordisk offers an immediate supply option (one-time per patient per year) where you can get a printable voucher for up to 3000 units of one or a combination of insulins for free, to cover in case of emergencies. For Humalog users, Lilly offers a flat $35/month option. For higher deductibles, the better options are the $99 programs which limit out-of-pocket spending to $99 for one or a combination of insulins. For lower deductibles, use a savings card, which typically drops a copay to $25/month while applying a certain dollar amount to the deductible. Here are the patient assistance links where you can print out the forms.įor Novolog, Tresiba, Levemir, Fiasp users: CLICK HEREįor Basaglar and Humalog users: CLICK HEREįor Apidra, Lantus, and Toujeo users: CLICK HEREĪnother great resource is where all drug patient assistance forms are available for download.įor folks with commercial insurance, the challenge is often meeting the deductible.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |